ADmit Therapeutics
Focused on the development and commercialization of a novel Alzheimer's disease (AD) early detection technology.
ADmit Therapeutics has raised €200k across 1 funding round from 1 investor, most recently a Seed round in Jan 2019. Based in Barcelona, Spain; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€200k
€200,000
Funding rounds
1
Investors
1
distinct backers
Active since
2019-01
latest 2019-01
Funding by year
EUR raised per yearADmit Therapeutics — funding by year — interactive chart.
Data table
| ADmit Therapeutics — funding by year | |
|---|---|
| 2018 | €200k |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Seed | €200k | Ship2B Ventures | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData